Search filters

List of works by Gunter von Minckwitz

13th st. Gallen international breast cancer conference 2013: primary therapy of early breast cancer evidence, controversies, consensus - opinion of a german team of experts (zurich 2013).

scientific article

14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts

scientific article

A randomized phase 2 study comparing EC or CMF versus nab-paclitaxel plus capecitabine as adjuvant chemotherapy for nonfrail elderly patients with moderate to high-risk early breast cancer (ICE II-GBG 52).

scientific article published on 25 June 2015

ABC1 Consensus Conference - a German Perspective: First International Consensus Conference on Advanced Breast Cancer (ABC1), Lisbon, November 5, 2011.

scientific article published on 30 January 2012

Adherence to Treatment Guidelines in Breast Cancer Care - a Retrospective Analysis of the 'Organgruppe Mamma der Arbeitsgemeinschaft Gynaekologische Onkologie'

scientific article

Adjuvant and Neoadjuvant Therapy with Lapatinib in ErbB2-Overexpressing Breast Cancer

scientific article

Adjuvant endocrine treatment with medroxyprogesterone acetate or tamoxifen in stage I and II endometrial cancer--a multicentre, open, controlled, prospectively randomised trial.

scientific article published in November 2002

Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patients

scientific article published on 09 December 2012

Adjuvant trastuzumab in HER2-positive breast cancer

scientific article published on October 2011

Agreement between MRI and pathologic breast tumor size after neoadjuvant chemotherapy, and comparison with alternative tests: individual patient data meta-analysis

scientific article

Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial

scientific article published on 11 December 2015

Androgen receptor expression in primary breast cancer and its predictive and prognostic value in patients treated with neoadjuvant chemotherapy

scientific article published on 12 August 2011

Aromatase inhibitors in the treatment of elderly women with metastatic breast cancer

scientific article published on 12 January 2013

Bendamustine in Metastatic Breast Cancer: An Old Drug in New Design

scientific article

Bendamustine prolongs progression-free survival in metastatic breast cancer (MBC): a phase III prospective, randomized, multicenter trial of bendamustine hydrochloride, methotrexate and 5-fluorouracil (BMF) versus cyclophosphamide, methotrexate and

scientific article published on 01 September 2005

Breakthrough for neoadjuvant chemotherapy

scientific article published on 01 January 2008

Breakthroughs in research and treatment of early breast cancer: an overview of the last three decades

scientific article

Breast Cancer Diagnosed During Pregnancy: Adapting Recent Advances in Breast Cancer Care for Pregnant Patients

scientific article

Breast cancer in the elderly.

scientific article

Breast carcinoma during pregnancy. International recommendations from an expert meeting

scientific article published on 01 January 2006

CD44 isoforms in prognosis of breast cancer

scientific article published in August 1995

CD44 variant exon epitopes in primary breast cancer and length of survival

scientific article published in March 1995

CMF versus goserelin as adjuvant therapy for node-negative, hormone-receptor-positive breast cancer in premenopausal patients: a randomised trial (GABG trial IV-A-93)

scientific article published on 12 June 2006

Capecitabine plus paclitaxel versus epirubicin plus paclitaxel as first-line treatment for metastatic breast cancer: efficacy and safety results of a randomized, phase III trial by the AGO Breast Cancer Study Group ⬇️

scientific article published on June 15, 2013

Chemotherapy for metastatic breast cancer-report of a European expert panel

scientific article

Chemotherapy for ovarian germ cell tumours

scientific article published on 01 April 1996

Clinical feasibility of (neo)adjuvant taxane-based chemotherapy in older patients: analysis of >4,500 patients from four German randomized breast cancer trials

scientific article published on 16 September 2008

Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast

scientific article published on April 2008

Clinical response by palpation during primary systemic therapy with four dose-dense cycles doxorubicin and docetaxel in patients with operable breast cancer: further results from a randomised controlled trial

scientific article published on 04 June 2007

Combination of new biologic parameters as a prognostic index in epithelial ovarian carcinoma.

scientific article published on January 1995

Combination versus sequential single-agent therapy in metastatic breast cancer.

scientific article

Comparison of pegfilgrastim on day 2 vs. day 4 as primary prophylaxis of intense dose-dense chemotherapy in patients with node-positive primary breast cancer within the prospective, multi-center GAIN study: (GBG 33) ⬇️

scientific article published on October 16, 2010

Correction: Phase I clinical study of the recombinant antibody-toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas.

scientific article

Cross-reactive staining of normal bone-marrow cells by monoclonal antibody 2E11

scientific article published on 01 October 1999

Current and future role of neoadjuvant therapy for breast cancer

scientific article published on 14 July 2014

Darbepoetin alfa as primary prophylaxis of anemia in patients with breast cancer treated preoperatively with docetaxel/doxorubicin/cyclophosphamide

scientific article published on 01 January 2006

Demographic and psychosocial factors associated with risk perception for breast cancer.

scientific article published in December 2005

Diagnosis of pathological complete response to neoadjuvant chemotherapy in breast cancer by minimal invasive biopsy techniques

scientific article

Docetaxel-related side effects and their management

scientific article

Docetaxel-related side effects and their management

scientific article published on 07 February 2009

Docetaxel/anthracycline combinations for breast cancer treatment

scientific article

Dose-dense intensified sequential versus conventionally-dosed anthracycline and taxane-containing neoadjuvant therapy in patients with inflammatory breast cancer

scientific article published on 01 August 2012

Downregulation of human polo-like kinase activity by antisense oligonucleotides induces growth inhibition in cancer cells

scientific article published on 01 May 2002

Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study

scientific article published on 02 May 2011

Effect of menstrual phase on surgical treatment of breast cancer

Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: ZO-FAST Study results.

scientific article published in March 2008

Effective oral chemotherapy for breast cancer: pillars of strength.

scientific article

Efficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST Study.

scientific article published on 5 May 2010

Efficacy, effectiveness and safety of long-acting granulocyte colony-stimulating factors for prophylaxis of chemotherapy-induced neutropenia in patients with cancer: a systematic review

scientific article

Evaluating the impact of Relative Total Dose Intensity (RTDI) on patients' short and long-term outcome in taxane- and anthracycline-based chemotherapy of metastatic breast cancer- a pooled analysis

scientific article

Evidence-based treatment of metastatic breast cancer - 2006 recommendations by the AGO Breast Commission

scientific article published on November 2006

Exploratory Cost-Effectiveness Analysis of Response-Guided Neoadjuvant Chemotherapy for Hormone Positive Breast Cancer Patients

scientific article published on 28 April 2016

Expression of endothelial and inducible nitric oxide synthase in benign and malignant lesions of the breast and measurement of nitric oxide using electron paramagnetic resonance spectroscopy

scientific article published on 5 September 2002

Febrile neutropenia and related complications in breast cancer patients receiving pegfilgrastim primary prophylaxis versus current practice neutropaenia management: results from an integrated analysis.

scientific article published on 26 December 2008

First-line therapy with moderate dose capecitabine in metastatic breast cancer is safe and active: Results of the MONICA trial ⬇️

scientific article published on August 24, 2010

German adjuvant intergroup node-positive study: a phase III trial to compare oral ibandronate versus observation in patients with high-risk early breast cancer

scientific article

Gross cystic disease fluid protein 15 (GCDFP-15) expression in breast cancer subtypes

scientific article

HER-2/neu as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxel.

scientific article published in August 2004

HER2 and ESR1 mRNA expression levels and response to neoadjuvant trastuzumab plus chemotherapy in patients with primary breast cancer

scientific article published on 7 February 2013

Identification of biology-based breast cancer types with distinct predictive and prognostic features: role of steroid hormone and HER2 receptor expression in patients treated with neoadjuvant anthracycline/taxane-based chemotherapy

scientific article published on January 2009

Identifying gaps in the locoregional management of early breast cancer: highlights from the Kyoto Consensus Conference.

scientific article

Immunohistochemical evaluation of endothelial nitric oxide synthase expression in primary breast cancer

scientific article published in June 2005

Impact of treatment characteristics on response of different breast cancer phenotypes: pooled analysis of the German neo-adjuvant chemotherapy trials

scientific article published on 03 November 2010

Improved overall survival in postmenopausal women with early breast cancer after anastrozole initiated after treatment with tamoxifen compared with continued tamoxifen: the ARNO 95 Study

scientific article published on 11 June 2007

In vivo chemosensitivity-adapted preoperative chemotherapy in patients with early-stage breast cancer: the GEPARTRIO pilot study.

scientific article published in January 2005

In vivo microscopy of murine islets of Langerhans: increased adhesion of transferred lymphocytes to islets depends on macrophage-derived cytokines in a model of organ-specific insulitis

scientific article published on 01 September 1999

Intense dose-dense sequential chemotherapy with epirubicin, paclitaxel, and cyclophosphamide compared with conventionally scheduled chemotherapy in high-risk primary breast cancer: mature results of an AGO phase III study

scientific article

International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations

scientific article

Ki67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trial.

scientific article

Lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-taxane-based chemotherapy (GeparQuinto, GBG 44): a randomised phase 3 trial ⬇️

scientific article published on January 17, 2012

Lessons from the neoadjuvant setting on how best to choose adjuvant therapies

scientific article published on October 2011

Locoregional treatment of primary breast cancer: consensus recommendations from an International Expert Panel

scientific article published on March 2010

Long-Term Partial Remission with Capecitabine/Trastuzumab in a Patient with Metastatic Breast Cancer Following Progression on Trastuzumab Alone

scientific article published on 21 February 2012

Macrophage and lymphocyte homing in experimental diabetes

scientific article published on 01 January 1999

Male breast cancer: 20-year survival data for post-mastectomy radiotherapy

scientific article

Methylation of estrogen receptor beta promoter correlates with loss of ER-beta expression in mammary carcinoma and is an early indication marker in premalignant lesions

scientific article published on 01 December 2005

Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer.

scientific article published on 4 December 2007

Mitomycin C, 5-fluorouracil and folinic acid (Mi-Fu-Fo) as salvage chemotherapy in breast cancer patients with liver metastases and impaired hepatic function: a phase II study.

scientific article

Monitoring serum HER2 levels during neoadjuvant trastuzumab treatment within the GeparQuattro trial

scientific article published on 10 July 2010

Multicenter Phase II Study with Weekly Bendamustine and Paclitaxel as First- or Later-Line Therapy in Patients with Metastatic Breast Cancer: RiTa II Trial

scientific article published on 15 December 2011

Multicenter phase III randomized trial comparing docetaxel and trastuzumab with docetaxel, carboplatin, and trastuzumab as first-line chemotherapy for patients with HER2-gene-amplified metastatic breast cancer (BCIRG 007 study): two highly active th

scientific article

Neoadjuvant Chemotherapy: Early Response as a Guide for Further Treatment: Clinical, Radiological, and Biological ⬇️

scientific article published on January 1, 2011

Neoadjuvant Therapy - What Have We Achieved in the Last 20 Years?

scientific article published on 15 December 2011

Neoadjuvant Treatment of Breast Cancer

scientific article published on 16 December 2011

Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial

scientific article

Neoadjuvant chemotherapy in breast cancer-insights from the German experience.

scientific article

Neoadjuvant chemotherapy shows similar response in patients with inflammatory or locally advanced breast cancer when compared with operable breast cancer: a secondary analysis of the GeparTrio trial data

scientific article

Neoadjuvant chemotherapy with paclitaxel and everolimus in breast cancer patients with non-responsive tumours to epirubicin/cyclophosphamide (EC)±bevacizumab – Results of the randomised GeparQuinto study (GBG 44) ⬇️

scientific article published on March 27, 2013

Neoadjuvant therapy: what are the lessons so far?

scientific article published on August 2013

Neoadjuvant treatments for triple-negative breast cancer (TNBC).

scientific article published on August 2012

Neoadjuvant, anthracycline-free chemotherapy with carboplatin and docetaxel in triple-negative, early-stage breast cancer: a multicentric analysis of feasibility and rates of pathologic complete response

scientific article published in January 2013

Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

scientific article

New endocrine approaches in the treatment of breast cancer

scientific article published on 01 January 1998

New therapies lower risk of recurrence. Hope for healing in breast carcinoma? (interview by Dr. Judith Neumaier)

scientific article published in July 2005

O6-methylguanine-DNA methyltransferase activity in breast and brain tumors.

scientific article published in May 1995

Optimizing taxane use in MBC in the emerging era of targeted chemotherapy ⬇️

scientific article published on October 30, 2012

Outcome after neoadjuvant chemotherapy in young breast cancer patients: a pooled analysis of individual patient data from eight prospectively randomized controlled trials

scientific article

Pathologic Complete Response After Neoadjuvant Chemotherapy Plus Trastuzumab Predicts Favorable Survival in Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: Results From the TECHNO Trial of the AGO and GBG Study Groups ⬇️

scientific article published on July 25, 2011

Pathologic complete response after neoadjuvant therapy of breast cancer: pitfalls and shortcomings ⬇️

scientific article published on 01 April 2012

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis

scientific article published on 14 February 2014

Pathway-oriented concepts in adjuvant and neoadjuvant breast cancer therapy.

scientific article published on August 2013

Pegfilgrastim +/- ciprofloxacin for primary prophylaxis with TAC (docetaxel/doxorubicin/cyclophosphamide) chemotherapy for breast cancer. Results from the GEPARTRIO study

scientific article published on 09 September 2007

Pegfilgrastim primary prophylaxis vs. current practice neutropenia management in elderly breast cancer patients receiving chemotherapy

scientific article published on 11 September 2009

Personalization of loco-regional care for primary breast cancer patients (part 1).

scientific article published in January 2015

Personalization of loco-regional care for primary breast cancer patients (part 2).

scientific article published on January 2015

Phase I clinical study of the recombinant antibody toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas

scientific article

Phase I dose finding study evaluating the combination of bendamustine with weekly paclitaxel in patients with pre-treated metastatic breast cancer: RiTa trial

scientific article

Phase II study of gemcitabine in ovarian cancer

scientific article published on 01 July 1999

Poor outcome in estrogen receptor-positive breast cancers predicted by loss of plexin B1

scientific article published on 01 February 2007

Prediction of Response to Neoadjuvant Chemotherapy: New Biomarker Approaches and Concepts

scientific article published on 29 August 2011

Predictive value of serum interleukin-6 and -8 levels in preterm labor or rupture of the membranes

scientific article published on 01 August 2000

Preoperative (neoadjuvant) systemic treatment of breast cancer

scientific article

Preoperative systemic therapy in locoregional management of early breast cancer: highlights from the Kyoto Breast Cancer Consensus Conference.

scientific article

Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease

scientific article published on February 2008

Preoperative therapy: what, when and for whom?

scientific article published on 01 July 2008

Present and future breast cancer management--bench to bedside and back: a positioning paper of academia, regulatory authorities and pharmaceutical industry.

scientific article published on 18 December 2013

Preventive therapy for breast cancer: a consensus statement

scientific article published on May 2011

Primary systemic therapy of carcinoma of the breast - update of the geparduo studies ⬇️

scientific article published on September 1, 2003

Prognostic and predictive impact of the HER-2/ neu extracellular domain (ECD) in the serum of patients treated with chemotherapy for metastatic breast cancer.

scientific article published in July 2004

Prognostic importance of DNA-ploidy and S-phase fraction in endometrial cancer

scientific article published on 01 July 1994

Prognostic significance of cell kinetic parameters of endometrial cancer

scientific article published on 01 September 1989

Prospective Biomarker Trials Chemo N0 and NNBC-3 Europe Validate the Clinical Utility of Invasion Markers uPA and PAI-1 in Node-Negative Breast Cancer.

scientific article published on 16 October 2008

Prospective cohort study using the breast cancer spheroid model as a predictor for response to neoadjuvant therapy--the SpheroNEO study

scientific article published on 15 July 2015

Prospective evaluation of prognostic factors uPA/PAI-1 in node-negative breast cancer: phase III NNBC3-Europe trial (AGO, GBG, EORTC-PBG) comparing 6×FEC versus 3×FEC/3×Docetaxel

scientific article

Prospective randomized studies are needed to define the role of axillary lymph node dissection in primary breast cancer

scientific article published on 01 August 1997

Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer.

scientific article

Prospective validation of immunological infiltrate for prediction of response to neoadjuvant chemotherapy in HER2-negative breast cancer--a substudy of the neoadjuvant GeparQuinto trial

scientific article

RANK expression as a prognostic and predictive marker in breast cancer.

scientific article published on 16 April 2014

Radiological Patterns of Brain Metastases in Breast Cancer Patients: A Subproject of the German Brain Metastases in Breast Cancer (BMBC) Registry

scientific article published on 23 September 2016

Randomized Phase III Trial of Sequential Adjuvant Chemoradiotherapy With or Without Erythropoietin Alfa in Patients With High-Risk Cervical Cancer: Results of the NOGGO-AGO Intergroup Study ⬇️

scientific article published on August 22, 2011

Randomized phase III trial of pegylated liposomal doxorubicin versus vinorelbine or mitomycin C plus vinblastine in women with taxane-refractory advanced breast cancer.

scientific article published in October 2004

Re-Challenging Taxanes in Recurrent Breast Cancer in Patients Treated with (Neo-)Adjuvant Taxane-Based Therapy

scientific article published on 19 August 2011

Recent advances in systemic therapy: advances in neoadjuvant (primary) systemic therapy with cytotoxic agents

scientific article published on 17 March 2009

Recommendations from an international consensus conference on the current status and future of neoadjuvant systemic therapy in primary breast cancer.

scientific article published on 23 December 2011

Reduced incidence of severe palmar-plantar erythrodysesthesia and mucositis in a prospective multicenter phase II trial with pegylated liposomal doxorubicin at 40 mg/m2 every 4 weeks in previously treated patients with metastatic breast cancer

scientific article published on 26 April 2006

Regression of cutaneous tumor lesions in patients intratumorally injected with a recombinant single-chain antibody-toxin targeted to ErbB2/HER2

scientific article published on 01 December 2003

Reply to Ki67 in breast cancer: a useful prognostic marker!

scientific article published on 15 January 2014

Response and prognosis after neoadjuvant chemotherapy in 1,051 patients with infiltrating lobular breast carcinoma

scientific article published on 07 February 2014

Responsiveness of adjacent ductal carcinoma in situ and changes in HER2 status after neoadjuvant chemotherapy/trastuzumab treatment in early breast cancer--results from the GeparQuattro study (GBG 40)

scientific article published on 12 June 2011

Second International Consensus Conference on Advanced Breast Cancer (ABC2), Lisbon, 11/09/2013: The German Perspective

scientific article

Selecting the neoadjuvant treatment by molecular subtype: how to maximize the benefit?

scientific article published on August 2013

Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study ⬇️

scientific article published on May 15, 2013

Side effects of standard adjuvant and neoadjuvant chemotherapy regimens according to age groups in primary breast cancer

scientific article published on March 2013

Sorafenib in the Treatment of Early Breast Cancer: Results of the Neoadjuvant Phase II Study - SOFIA.

scientific article

Surgical outcome after neoadjuvant chemotherapy and bevacizumab: results from the GeparQuinto study (GBG 44)

scientific article published on 18 April 2014

Surgical procedures after neoadjuvant chemotherapy in operable breast cancer: results of the GEPARDUO trial

scientific article published on 17 September 2006

Survival benefit from response-guided approach: a direct effect of more effective cytotoxic regimens or an indirect effect of chemotherapy-induced amenorrhea? Reply to K.-D. Yu et al

scientific article published on 17 March 2014

Tamoxifen versus control after adjuvant, risk-adapted chemotherapy in postmenopausal, receptor-negative patients with breast cancer: a randomized trial (GABG-IV D-93)--the German Adjuvant Breast Cancer Group.

scientific article published in November 2005

The GISS trial: a phase II prevention trial of screening plus goserelin, ibandronate, versus screening alone in premenopausal women at increased risk of breast cancer

scientific article published on 27 July 2011

The clinical benefit of pegylated liposomal doxorubicin in patients with metastatic breast cancer previously treated with conventional anthracyclines: a multicentre phase II trial

scientific article published on June 2006

The impact of breast cancer awareness and socioeconomic status on willingness to receive breast cancer prevention drugs

scientific article published on 11 October 2006

The reawakening of bendamustine - also in breast cancer?

scientific article published on 12 August 2009

The role of early expression of inducible nitric oxide synthase in human breast cancer

scientific article published in January 2005

Therapy concept: herceptin in combination with arimidex

scientific article published on December 1, 2002

There are now evidence-based guidelines for breast carcinoma. There are evidence-based guidelines for breast carcinoma. Individual therapy out? (interview by Dr. Judith Neumaier)

scientific article published in June 2002

Thymosin beta 15A (TMSB15A) is a predictor of chemotherapy response in triple-negative breast cancer ⬇️

scientific article published on October 18, 2012

Topotecan chemotherapy in patients with breast cancer and brain metastases: results of a pilot study.

scientific article published on June 2001

Transforming growth factor-beta stimulates urokinase expression in tumor-associated macrophages of the breast.

scientific article published on January 1998

Trastuzumab Improves the Efficacy of Chemotherapy in Breast Cancer Treatment beyond Progression

scientific article

Trastuzumab beyond progression in human epidermal growth factor receptor 2-positive advanced breast cancer: a german breast group 26/breast international group 03-05 study.

scientific article

Trastuzumab beyond progression: overall survival analysis of the GBG 26/BIG 3-05 phase III study in HER2-positive breast cancer

scientific article published on 07 July 2011

Trastuzumab single-drug therapy after failure of cytotoxic treatment for metastatic breast cancer.

scientific article published on 27 July 2010

Update on neoadjuvant/preoperative therapy of breast cancer: experiences from the German Breast Group

scientific article published on February 2013

Use of goserelin in the treatment of breast cancer

scientific article

Venlafaxine is superior to clonidine as treatment of hot flashes in breast cancer patients--a double-blind, randomized study

scientific article published on 17 January 2007

What can be learned from trials running short of patients or events?

scientific article published on 13 February 2012

What is the current standard of care for anti-HER2 neoadjuvant therapy in breast cancer?

scientific article published on January 1, 2012

Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results

scientific article published on 09 October 2012

Zurich Consensus: German Expert Opinion on the St. Gallen Votes on 15 March 2009 (11th International Conference at St. Gallen: Primary Therapy of Early Breast Cancer).

scientific article

[Breast cancer: analysis of treatment quality in Germany 2004: retrospective survey by Arbeitsgemeinschaft Gynäkologische Onkologie (AGO)]

scientific article published on 01 December 2006

[Docetaxel (taxotere) for therapy of breast carcinoma. Highest effectiveness with moderate side effects]

scientific article published on 01 September 1997

[Evidence-based recommendations on primary treatment of carcinomas of the breast]

scientific article published on 01 May 2002

[Evidence-based recommendations on treating locoregional and distant metastases of carcinomas of the breast]

scientific article published on 01 May 2002

[New aspects of carcinoma of the breast therapy and of gynaecological carcinoma treatment]

scientific article published on 01 September 2003

[New strategies for therapy of breast cancer. San Antonio Breast Cancer Symposium, 2002]

scientific article published on 01 October 2002

[Predictive and prognostic factors in breast cancer evaluated by immunohistological methods]

scientific article published on 01 January 2001

[Preoperative chemotherapy in breast cancer and the development of new predictive markers]

scientific article published on 01 January 2006

[Preoperative chemotherapy of breast carcinoma]

scientific article published on 01 January 1998

[Report on the NIH Consensus Development Conference on Adjuvant Therapy of Breast Carcinoma]

scientific article published on 01 April 2001

[Systemic therapy of operable carcinoma of the breast]

scientific article published on 01 August 2005

[The role of stereotactic 11G vacuum biopsy for clarification of BI-RADS IV findings in mammography]

scientific article published on 01 April 2003

[Therapeutic strategy in advanced breast carcinoma]

scientific article published on 01 April 1998

[Value of steroid hormone receptors as prognostic factors in breast, ovarian and endometrial cancer]

scientific article published on 01 April 1993

pCR rates in patients with bilateral breast cancer after neoadjuvant anthracycline-taxane based-chemotherapy - A retrospective pooled analysis of individual patients data of four German neoadjuvant trials

scientific article

uPA and PAI-1 in breast cancer: review of their clinical utility and current validation in the prospective NNBC-3 trial.

scientific article published on January 2008

Paulina is supported by:

About Paulina

Help